Daniele Rossini Selected Research

Sorafenib (BAY 43-9006)

12/2022

KDR genetic predictor of toxicities induced by sorafenib and regorafenib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniele Rossini Research Topics

Disease

49	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2015
16	Neoplasms (Cancer) 11/2023 - 01/2013
8	Disease Progression 01/2023 - 01/2018
6	Neoplasm Metastasis (Metastasis) 09/2023 - 10/2015
5	Neutropenia 01/2023 - 01/2015
2	Hypertension (High Blood Pressure) 12/2022 - 02/2022
2	Diarrhea 12/2022 - 08/2020
2	Febrile Neutropenia 01/2022 - 08/2020
1	Triple Negative Breast Neoplasms 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Neoplasm Micrometastasis 01/2023
1	Myocardial Infarction 01/2022
1	Obesity 01/2022
1	Microsatellite Instability 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Adenocarcinoma 01/2019
1	Infarction (Infarctions) 01/2018
1	Necrosis 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2015
9	Irinotecan (Camptosar)FDA LinkGeneric 09/2023 - 01/2018
8	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2016
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 01/2018
8	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2017
6	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2018
6	Panitumumab (Vectibix)FDA Link 12/2023 - 01/2018
5	Cetuximab (Erbitux)FDA Link 09/2023 - 01/2018
5	Monoclonal AntibodiesIBA 01/2023 - 10/2015
4	regorafenibIBA 10/2023 - 10/2020
4	trifluridine tipiracil drug combinationIBA 10/2023 - 01/2015
4	atezolizumabIBA 01/2023 - 07/2020
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
3	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2016
2	Circulating Tumor DNAIBA 04/2024 - 01/2023
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 08/2017
2	AntibodiesIBA 01/2020 - 01/2016
1	Messenger RNA (mRNA)IBA 10/2023
1	encorafenibIBA 09/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 12/2022
1	SaltsIBA 01/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	avelumabIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	afliberceptIBA 05/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Exonucleases (3' 5' Exonuclease)IBA 12/2019
1	Codon (Codons)IBA 12/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Angiopoietin-like ProteinsIBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	LigandsIBA 08/2017
1	Interleukin-8 (Interleukin 8)IBA 08/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2017
1	Fibrinogen (Factor I)FDA Link 02/2015
1	Lactate DehydrogenasesIBA 02/2015

Therapy/Procedure

19	Therapeutics 11/2023 - 02/2015
16	Drug Therapy (Chemotherapy) 12/2023 - 01/2013
3	Radiotherapy 01/2023 - 01/2013
2	Retreatment 01/2023 - 01/2020
1	Hepatectomy 09/2023
1	Consolidation Chemotherapy 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Neoadjuvant Therapy 01/2023